Detection of extrathoracic manifestations in sarcoidosis with somatostatin analogue scintigraphy

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 14, Issue 2, 1997, Pages 146-151

  Eklund, Anders ^a,b   Jacobsson, Hans ^b   Larsson, Stig A ^b   Magnus Skold C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Extrathoracic manifestations; Granulomatous disorders; Octreotide; Radionucleide investigation; Sarcoidosis; Somatostatin analogue

Indexed keywords

OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOMA; HUMAN; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SARCOIDOSIS; SCINTIGRAPHY;

ADULT; BIOPSY; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; SARCOIDOSIS;

EID: 0030820967     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Keogh BA, Hunninghake GW, Line BR, Cystal RG: Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis 1983; 128: 256-265.
2. 99cmTc-DTPA clearance measured by a dual-head gamma-camera in healthy subjects and in sarcoidosis. Studies of reproducibility and relation to bronchoalveolar lavage findings. Eur J Nucl Med 1989; 15: 71-77.
3. Line BR: Scintigraphic studies of inflammation in diffuse lung disease. Radiol Clin N Am 1991; 29: 1095-1114.
4. Israel HL, Albertine KH, Park CH, Patrick H: Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991; 144: 1182-1186.
5. Diot P, Lemarié E, Baulieu JL et al: Scintigraphy with J001 macrophage targeting glycolipopeptide. A new approach for sarcoidosis imaging. Chest 1992; 102: 670-676.
6. Myslivecek M, Husak V, Kolek V, Budikova M, Koranda P: Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis. Eur J Nucl Med 1992; 19: 1016-1022.
7. 67Ga images in the noninvasive diagnosis of sarcoidosis. Chest 1993; 103: 403-409.
8. 1]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
9. Öztürk E, Günalp B, Özgüven M et al: The visualization of granulomatous disease with somatostatin receptor scintigraphy. Clin Nucl Med 1994; 2: 129-132.
10. Durak I, Durak H, Ergin M, Yürekli Y, Kaynak S: Somatostatin receptors in the orbits. Clin Nucl Med 1995, 20: 237-242.
11. Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ: Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990; 31: 1909-1914.
12. Özgüven MA, Civelek AC, Abernathy EC, Camargo EE: Testicular involvement of sarcoidosis diagnosed by gallium-67 scintigraphy. Eur J Nucl Med 1991; 18: 507-510.
13. Vanhagen PM, Krenning EP, Reubi JC et al: Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994; 21: 497-502.
14. Weinstock JV, Blum AM, Malloy T: Macrophages within the granulomas of murine Schistosoma mansoni are source of a somatostatin 1-14-like molecule. Cell Immunol 1990; 131: 381-390.
15. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci 1992; 89: 251-255.
16. Yamada Y, Reisine T, Law SF et al: Somatostatin receptors; an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenyl cyclase. Mol Endocrinol 1992; 6: 2136-2142.
17. 11In-DTPA-D-Phe']-octreotide. Acta Oncol 1993; 32: 783-786.
18. 1] octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment. Eur J Endocrinol 1994; 131: 577-581.
19. Bajc M, Ingvar C, Persson B et al: Dynamic octreotide scintigraphy in neuroendocrine tumours. Acta Radiol 1995; 36: 474-477.
20. Kwekkeboom DJ, Kho GS, Lambert SWJ, Reubi JC, Laissue JA, Krenning EP: The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994; 21: 1106-1113.
21. 111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer. J Nucl Biol Med 1994; 38: 576-578.
22. Weinel RJ, Kisker O, Joseph K, Welcke U, Zaraca F, Rothmund M: Die Somatostatin-receptor-Scintigraphie in der präoperativen Lokalisationsdiagnostik endokriner gastrointestinaler Tumoren. Chirurg 1994; 65: 849-855.
23. Krenning EP, Kwekkeboom DJ, Oei HY et al: Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing's syndrome. Digestion 1994; 55(suppl 3): 54-59.
24. Krenning EP, Bakker WH, Kooij PPM et al: Somatostatin receptor scintigraphy with In-111-DTPA-D-Phe-1-Octreotide in man: Metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Ed 1992; 5: 652-658.
25. Annals of the ICRP: Radiation dose to patients from radiopharmaceuticals, ICRP publ. 53, 1987, Vol.18, No 1-4.